Close

Affimed (AFMD) Announces Collaboration with Roche to Study AFM24 in Combination with PD-L1 Checkpoint Inhibitor in EGFR Expressing Solid Tumors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. SPY
3. SPOT
4. GM
5. AMZN
6. NVDA
7. SHW
8. MSCI
9. IBM
10. MSFT


Go back to Affimed (AFMD) Announces Collaboration with Roche to Study AFM24 in Combination with PD-L1 Checkpoint Inhibitor in EGFR Expressing Solid Tumors
(NASDAQ: AFMD) Delayed: 5.35 --0 (-0%)
Previous Close $5.35    52 Week High $8.26 
Open $5.35    52 Week Low $1.75 
Day High $5.35    P/E N/A 
Day Low $5.35    EPS $0.00 
Volume 181